Endogenous ligands and co-administered drugs

The term Endogenous ligands and co-administered drugs refers to a broad classification of chemical entities that interact with biological systems alongside a primary therapeutic agent. Endogenous ligands are naturally occurring substances, such as hormones, neurotransmitters, and metabolites, that bind to specific receptors or enzymes to regulate physiological processes (StatPearls, 2023). Co-administered drugs are exogenous substances taken concurrently that may compete for the same molecular targets or metabolic pathways, such as Cytochrome P450 enzymes (FDA, 2020). This category is not a single therapeutic target but rather a critical consideration in pharmacology for assessing drug-drug interactions, competitive binding, and overall clinical safety. Because it encompasses a vast array of unrelated molecules, it cannot be classified as a specific protein, gene, or receptor. Understanding the interplay between these substances is essential for predicting the pharmacokinetic and pharmacodynamic profile of new chemical entities during drug development (NIH, 2021).

Other names

Endogenous substancesConcomitant medicationsInteracting ligandsEndogenous substrates

Not applicable as this is a category of substances rather than a specific molecular target; however, these entities typically act through competitive binding, allosteric modulation, or metabolic interference.